InflaRx
IFRX
20 hedge funds and large institutions have $20.9M invested in InflaRx in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
87% more capital invested
Capital invested by funds: $11.2M → $20.9M (+$9.73M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
11% more funds holding
Funds holding: 18 → 20 (+2)
2.78% more ownership
Funds ownership: 17.48% → 20.26% (+2.8%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EP
Eversept Partners
New York
|
+$978K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$964K |
| 3 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$643K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$214K |
| 5 |
JP Morgan Chase
New York
|
+$183K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$741K |
| 2 |
Morgan Stanley
New York
|
-$349K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$276K |
| 4 |
Two Sigma Investments
New York
|
-$185K |
| 5 |
Goldman Sachs
New York
|
-$146K |
IFRX Hedge Fund Activity: Q4 2019 in Review
20 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2019, worth a combined $20.9M — up 87% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IFRX positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Eversept Partners, opening a new position worth an estimated $978K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $741K sold.
- 20 institutional investors held InflaRx (IFRX) as of Q4 2019, up from 18 in Q3 2019.
- Funds reported $20.9M of InflaRx stock for Q4 2019, up 87% quarter-over-quarter.
- 7 funds opened new InflaRx positions in Q4 2019 and 5 closed out, a net change of +2 holders.
- The largest InflaRx buyer in Q4 2019 was Eversept Partners, an estimated $978K added.
- The largest InflaRx seller in Q4 2019 was Cormorant Asset Management, an estimated $741K sold.
Based on aggregated 13F filings for Q4 2019.